We are advisors on a mission to turn complex science into clear investable stories.
We deliver independent assessments that help investors make confident decisions and founders sharpen their story before they raise.
We help life sciences and healthcare ventures prioritise opportunities and scale effectively through pipeline assessment, market entry, commercial strategy, partnerships and portfolio optimisation.
We help CVCs and life science companies identify and assess ventures, and determine whether to build, buy, or partner.
We work only in MedTech, Biotech, Pharma and Health Tech.
If something is vague, we reduce it to what’s proven, assumed, and needs testing.
Hype cycles and loud opinions don’t sway us; verifiable data does.
We can talk trial protocols with scientists, product–market fit with founders, risk/return tradeoffs with investors – without switching personalities.
We turn complex findings into straightforward guidance and next steps.
Know what’s happening, what’s missing, and what to do next.
Direct time and capital to the issues that actually move the needle.
Make calls on data, not assumptions or pitch decks.
Keep founders, investors, corporates, and regulators working to the same plan.
Spot and solve the right problems early, avoiding costly delays later.
